Foamix Announces Publication of Phase 3 Studies Evaluating FMX103
06 Feb 2020 //
PR NEWSWIRE
OrbiMed Supports the Proposed Foamix. And Menlo Therapeutics Merger
16 Jan 2020 //
BUSINESS WIRE
Foamix Announces AMZEEQâ„¢ (minocycline) Achievement of Preferred Status P
14 Jan 2020 //
PR NEWSWIRE
Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial
18 Nov 2019 //
BIOSPACE
Foamix and Menlo Therapeutics Combine to Form Single Dermatology Company
12 Nov 2019 //
BIOSPACE